Copyright
©The Author(s) 2018.
World J Gastroenterol. Jun 21, 2018; 24(23): 2413-2426
Published online Jun 21, 2018. doi: 10.3748/wjg.v24.i23.2413
Published online Jun 21, 2018. doi: 10.3748/wjg.v24.i23.2413
Table 1 Gadolinium-based magnetic resonance imaging contrast agent
| Contrast agent | Category | Relaxivity | Structure | Concentration(mmol/mL) | Reccomended dosage (mmol/kg) |
| Gadoterate-meglumine | ECFAs | Standard | macrocyclic | 0.5 | 0.1 |
| Gadobutrol | ECFAs | Standard | macrocyclic | 1.0 | 0.1 |
| Gadoteridol | ECFAs | Standard | macrocyclic | 0.5 | 0.1 |
| Gadopentetate- dimeglumine | ECFAs | Standard | Linear | 0.5 | 0.1 |
| Gadoversetamide | ECFAs | Standard | Linear | 0.5 | 0.1 |
| Gadodiamide | ECFAs | Standard | Linear | 0.5 | 0.1 |
| Gadofosfaset-trisodium | BPCAs | High | Linear | 0.25 | 0.03 |
| Gadobenate- dimeglumine | HCAs | High | Linear | 0.5 | 0.1 |
| Gadoxetate-disodium | HCAs | High | Linear | 0.25 | 0.025 |
- Citation: Ippolito D, Inchingolo R, Grazioli L, Drago SG, Nardella M, Gatti M, Faletti R. Recent advances in non-invasive magnetic resonance imaging assessment of hepatocellular carcinoma. World J Gastroenterol 2018; 24(23): 2413-2426
- URL: https://www.wjgnet.com/1007-9327/full/v24/i23/2413.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i23.2413